Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs)

Theresa Weldring, Sheree M S Smith, Theresa Weldring, Sheree M S Smith

Abstract

In recent years, there has been an increased focus on placing patients at the center of health care research and evaluating clinical care in order to improve their experience and ensure that research is both robust and of maximum value for the use of medicinal products, therapy, or health services. This paper provides an overview of patients' involvement in clinical research and service evaluation along with its benefits and limitations. We describe and discuss patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs), including the trends in current research. Both the patient-reported experiences measures (PREMs) and patient and public involvement (PPI) initiative for including patients in the research processes are also outlined. PROs provide reports from patients about their own health, quality of life, or functional status associated with the health care or treatment they have received. PROMs are tools and/or instruments used to report PROs. Patient report experiences through the use of PREMs, such as satisfaction scales, providing insight into the patients' experience with their care or a health service. There is increasing international attention regarding the use of PREMS as a quality indicator of patient care and safety. This reflects the ongoing health service commitment of involving patients and the public within the wider context of the development and evaluation of health care service delivery and quality improvement.

Keywords: clinical research; patient experience; patient reported measures; patient reported outcomes.

References

    1. Tarlov AR, Ware JE, Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study. an application of methods for monitoring the results of medical care. JAMA. 1989;262(7):925–930.
    1. Food and Drug Administration; Services DoHaH, editor. Guidance for industry patient-related outcome measures: use in medical product development to support labeling claims. Washington: U.S. Department of Health and Human Services Food and Drug Administration; 2009.
    1. Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10(Suppl 2):S125–S137.
    1. Wilke RJ, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials. 2004;25(6):535–552.
    1. NHS Executive. Patient and public involvement in the new NHS. Leeds: Department of Health; 1999.
    1. Oliver SR. How can health services users contribute to the NHS research and development programme? BMJ. 1995;310(6990):1318–1320.
    1. Higgins JPT, Greene S, editors. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2011. [Accessed date]. Version 5.1.0 [updated March 2011]
    1. Black N. Patient reported outcome measures could help transform health care. BMJ. 2013;346:f167.
    1. Rathert C, Huddleston N, Pak Y. Acute care patients discuss the patient role in patient safety. Health Care Manage Rev. 2011;36(2):134–144.
    1. Using the commissioning for quality and innovation (CQUIN) payment framework. UK Department of Health; [Accessed date]. . Updated April 30, 2012.
    1. Black N, Jenkinson C. Measuring patients’ experiences and outcomes. BMJ. 2009;239:b2495.
    1. Guidance on the routine collection of Patient Reported Outcome Measures (PROMS) UK Department of Health; [Accessed date]. . Updated July 18, 2011.
    1. Bottomley A, Jones D, Claassaens L. Patient-reported outcomes: assessment and current persepctives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer. 2009;45(3):347–353.
    1. Darzi A. High quality care for all. NHS next stage review final report. Norfolk, UK: Stationary Office Books; 2008.
    1. University of Oxford. Patient Reported Outcomes Measurement Group. [Accessed date]. .
    1. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109.
    1. Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD. Use of existing patient-reported outcome (PRO) instruments and their modification: The ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO taskforce report. Value Health. 2009;12(8):1075–1083.
    1. Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes: conceptual issues. Value Health. 2007;10(2):S66–S77.
    1. Devlin JN, Appleby J, Buxton M, et al. In: Getting the most out of PROMS. Putting health outcomes at the heart of the NHS decision making. Fund TK, editor. London, UK: The Kings Fund; 2010.
    1. Carle AC, Cella D, Cai L, et al. Advancing PROMIS’s methodology: results of the Third Patient Reported Outcomes Measurement Information System (PROMIS®) Psychometric Summit. Expert Rev Pharmacoecon Outcomes Res. 2011;11(6):677–684.
    1. Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45(5 Supp 1):S3–S11.
    1. Edwards P, Roberts I, Clarke M, et al. Increasing response rates to postal questionnaires: systematic review. BMJ. 2002;324(7347):1183.
    1. Wild D, Grove A, Martin M, et al. ISPOR Task Force for Translation and Cultural Adaptation. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR taskforce for translation and cultural adaptation. Value Health. 2005;8(2):94–104.
    1. Greaves F, Ramirez-Cano D, Millett C, Darzi A, Donadson L. Harnessing the cloud of patient experience: using social media to detect poort quality healthcare. BMJ Qual Saf. 2013;22(3):251–255.
    1. Lagha E, Noble A, Smith A, Denvir MA, Leslie SJ. Patient reported experience measures (PREMS) in chronic heart failure. J R Coll Physicians Edinb. 2012;42(4):301–305.
    1. Lakhani A. Indicators for measuring patient experience. [Accessed April 18, 2013]. .
    1. Staniszewska S, Bullock I, Avital L, O’Flynn N. Developing and implementing NICE guidance on patient experience. [Accessed April 18, 2013]. .
    1. Lyu H, Wick EC, Housman M, Freischlag JA, Makary MA. Patient satisfaction as a possible indicator of quality surgical care. JAMA Surg. 2013;148(4):362–367.
    1. Doyal C, Lennox L, Bell D. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open. 2013;3(1):e001570.
    1. Glickman SW, Boulding W, Manary M, et al. Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2010;3(2):188–195.
    1. National Clinical Guideline Centre (UK) Patient experience in adult NHS services: improving the experience of care for people using adult NHS services: patient experience in generic terms. London, UK: Royal College of Physicians; 2012.
    1. Gibbons E, Fitzpatrick R. Patient reported outcomes measures: their roles in measuring and improving patient experience. [Accessed April 18, 2013]. .
    1. National Health Service. NHS Patient Experience Framework. 2011. [Accessed June 15, 2013]. .
    1. Boote J. Patient and public involvement in Health and Social Care Research: A bibliography: National Institute of Health Research (NIHR) [Accessed date]. .
    1. Boote J, Telford R, Cooper C. Consumer involvement in health research: a review and research agenda. Health Policy. 2002;61(2):213–236.
    1. Entwhistle VA, Renfrew MJ, Yearley S, Forrester J. Lay perspectives: advantages for health research. BMJ. 1998;316(7129):463–466.
    1. Chalmers I. What do I want from health research and researchers when I am a patient? BMJ. 1995;310(6990):1315–1318.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren